- SH-4-54
-
- $43.00 / 1mg
-
2026-05-11
- CAS:1456632-40-8
- Min. Order:
- Purity: 98.00%
- Supply Ability: 10g
- SH-4-54
-
- $200.00 / 1kg
-
2023-06-26
- CAS:1456632-40-8
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg/Months
|
| | SH-4-54 Basic information |
| Product Name: | SH-4-54 | | Synonyms: | 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-Benzoic Acid SH-4-54;SH-4-54;4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-benzoic acid;Benzoic acid, 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-;CS-1773;SH-4-54 USP/EP/BP;SH 4 54,Inhibitor,SH454,inhibit,STAT;SH-4-54, 10 mM in DMSO | | CAS: | 1456632-40-8 | | MF: | C29H27F5N2O5S | | MW: | 610.59 | | EINECS: | | | Product Categories: | Inhibitors;API | | Mol File: | 1456632-40-8.mol |  |
| | SH-4-54 Chemical Properties |
| Boiling point | 717.2±70.0 °C(Predicted) | | density | 1.431±0.06 g/cm3(Predicted) | | storage temp. | Desiccate at -20°C | | solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 20 mg/ml | | pka | 4.29±0.10(Predicted) | | form | A crystalline solid | | color | White to off-white | | InChIKey | VFPYGNNOSJWBHF-UHFFFAOYSA-N | | SMILES | C(O)(=O)C1=CC=C(N(CC2=CC=C(C3CCCCC3)C=C2)C(CN(C)S(C2=C(F)C(F)=C(F)C(F)=C2F)(=O)=O)=O)C=C1 |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | SH-4-54 Usage And Synthesis |
| Description | SH-4-54 is an inhibitor of signal transducer and activator of transcription 3 (STAT3; IC50 = 4.7 μM for STAT3 homodimer DNA binding activity). It selectively inhibits STAT3 homodimer over STAT1 and STAT5 homodimer and STAT3:STAT1 heterodimer DNA binding in EGF-stimulated NIH3T3/hEGFR nuclear extracts containing activated STAT1, STAT3, and STAT5 and decreases STAT3 iNOS, Survivin, and Bcl-2 promoter occupancy in MDA-MB-231 cells. SH-4-54 inhibits growth of glioma, breast, and prostate cancer cell lines that express constitutively active STAT3 (IC50s = 1-7.4, 3.8-4.5, and 5.3-5.8 μM, respectively). In vivo, SH-4-54 (3 mg/kg per day) inhibits tumor growth in the U251MG glioma and MDA-MB-231 breast cancer mouse xenograft models. | | Uses | 4-[[(4-Cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]benzoic Acid acts as a STAT 3 and STAT5 inhibitor. STAT 3 is unusually active in glioblastoma and plays a crucial role in tumor growth | | in vivo | SH-4-54 exhibits blood-brain barrier permeability potently controls glioma tumor growth, and inhibits pSTAT3 in vivo. SH-4-54 demonstrates the power of STAT3 inhibitors for the treatment of BTSCs and validates the therapeutic efficacy of a STAT3 inhibitor for GBM clinical application.SH-4-54 decreases pSTAT3 expression in tumor cells of treated mice. SH-4-54 appears to decrease proliferation and increase apoptosis of treated tumors[1]. | | IC 50 | STAT3: 300 nM (Kd); STAT5: 464 nM (Kd) | | References | [1] PEIBIN YUE. Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo.[J]. Cancer research, 2016, 76 3: 652-663. DOI: 10.1158/0008-5472.can-14-3558 |
| | SH-4-54 Preparation Products And Raw materials |
|